Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

Ovid Therapeutics (OVID)

Ovid Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OVID
DateTimeSourceHeadlineSymbolCompany
16/12/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
16/12/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
02/12/202413:00GlobeNewswire Inc.Ovid Therapeutics to Present Multiple Posters Supporting Its Pipeline Programs Targeting Neuronal Hyperexcitability at the American Epilepsy Society 2024 Annual MeetingNASDAQ:OVIDOvid Therapeutics Inc
12/11/202413:07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
12/11/202413:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
12/11/202413:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
31/10/202412:00GlobeNewswire Inc.Ovid Therapeutics to Host Investor EventNASDAQ:OVIDOvid Therapeutics Inc
26/09/202412:00GlobeNewswire Inc.Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with VigabatrinNASDAQ:OVIDOvid Therapeutics Inc
11/09/202421:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
11/09/202421:36Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:OVIDOvid Therapeutics Inc
11/09/202420:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
11/09/202412:00GlobeNewswire Inc.Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future GrowthNASDAQ:OVIDOvid Therapeutics Inc
04/09/202412:00GlobeNewswire Inc.Ovid Therapeutics to Present at Upcoming September Investor ConferencesNASDAQ:OVIDOvid Therapeutics Inc
13/08/202412:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
13/08/202412:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
13/08/202412:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
08/08/202412:00GlobeNewswire Inc.Ovid Therapeutics Appoints Dr. Amanda Banks, Experienced Biotech Leader & Physician as Chief Development OfficerNASDAQ:OVIDOvid Therapeutics Inc
02/08/202421:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
30/07/202412:00GlobeNewswire Inc.Ovid Therapeutics to Present at Upcoming August Investor ConferencesNASDAQ:OVIDOvid Therapeutics Inc
23/07/202412:00GlobeNewswire Inc.Ovid Therapeutics Expands Scientific Advisory Board with Appointments of Leading Neurologists, Neuroscientists and EpileptologistsNASDAQ:OVIDOvid Therapeutics Inc
10/07/202412:00GlobeNewswire Inc.eNeuro Publishes Findings on the Anti-Convulsant Properties of OV329 and Its Potential Effectiveness in Treatment-Resistant SeizuresNASDAQ:OVIDOvid Therapeutics Inc
01/07/202412:00GlobeNewswire Inc.Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous MalformationsNASDAQ:OVIDOvid Therapeutics Inc
17/06/202411:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
17/06/202410:55GlobeNewswire Inc.Ovid Therapeutics Reports on Takeda’s Announcement of Phase 3 Topline Study Results for SoticlestatNASDAQ:OVIDOvid Therapeutics Inc
07/06/202420:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
14/05/202421:19Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:OVIDOvid Therapeutics Inc
14/05/202412:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OVIDOvid Therapeutics Inc
14/05/202412:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OVIDOvid Therapeutics Inc
14/05/202412:00GlobeNewswire Inc.Ovid Therapeutics Reports Business Updates and First Quarter 2024 Financial ResultsNASDAQ:OVIDOvid Therapeutics Inc
13/05/202411:00GlobeNewswire Inc.Ovid Therapeutics to Present at the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:OVIDOvid Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:OVID